In September 2019, the FDA warned that the popular heartburn drug Zantac may contain cancer-causing impurities. These same chemicals have been linked to an increased risk of colorectal cancer, stomach cancer, liver cancer and other health problems.…
A class action lawsuits seeks compensation for the money plaintiffs spent on buying over-the-counter Zantac, without knowing it contained high levels of a potentially cancer-causing agent.…
Australian investigators say 75% of all Zantac tablets contain excessive amounts of NDMA, which is a suspected carcinogen.…
The initial petition warning of Zantac NDMA contamination calls for the drug to be recalled, special disposal instructions to prevent NDMA from contaminating the nation’s water supply, and new rules on how drugs are tested for chemical impurities.…
A Zantac recall announced by GlaxoSmithKline due to NDMA contamination affects all prescription-strength brand-name versions of the medication.…
The FDA says it has found “unacceptable” levels of NDMA in Zantac, even when using more forgiving testing procedures.…
A Zantac class action lawsuit calls for the manufacturers to pay back everyone who has bought the over-the-counter drug since January 2010, and to require warning labels indicating the presence of high levels of NDMA, a cancer-causing agent.…
The makers of Zantac face a class action lawsuit from plaintiffs in California, who say they knew or should have known the heartburn drug contained high levels of NDMA; which has been linked to an increased cancer risk.
…
All generic Zantac manufactured and distributed by Sandoz has been recalled due to NDMA contamination.…
The heartburn drug Zantac is being pulled from the market after a pharmacy found that it contained large amounts of a likely cancer-causing impurity.…
